Idiopathic inflammatory demyelinating diseases Information & Idiopathic inflammatory demyelinating diseases Links at HealthHaven.com
advertise
add site
services
publishers
database
health videos
Bookmark and Share

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 
about
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
Featured Results:
 Multiple Sclerosis symptom - multiple sclerosis early symptom, multiple
Multiple Sclerosis symptom - multiple sclerosis early symptom, multiple
diseasesatoz.com
  Multiple Sclerosis - Alternative Treatment for Multiple Sclerosis
Multiple Sclerosis - Alternative Treatment for Multiple Sclerosis
erinelster.com
  Multiple Sclerosis - symptom, Treatment of Multiple Sclerosis
Multiple Sclerosis - symptom, Treatment of Multiple Sclerosis
diseases-condition.com
 

Idiopathic Inflammatory Demyelinating Diseases (IIDDs), sometimes known as Borderline forms of multiple sclerosis[1], is a collection of multiple sclerosis variants, sometimes considered different diseases[2][3], but considered by others to form a spectrum differing only in terms of chronicity, severity, and clinical course.[4][5]

Contents

[edit] Multiple sclerosis definitions

No formal definition of MS is normally given. For example, the World Health Organization does not give any explicit definition with ICD-10 MS entry [2]. In ICD-9 it used to say "chronic disease characterized by presence of numerous areas of demyelination in the central nervous system with symptoms such as weakness, incoordination, paresthesis, and speech disturbances"[3].

The Unified Medical Language System also gives very loose definitions of MS [4]. The Medline medical dictionary defines it as "a demyelinating disease marked by patches of hardened tissue in the brain or the spinal cord and associated especially with partial or complete paralysis and jerking muscle tremor" [5]. It uses the anatomical hallmark of the lesions, but also imposes the existence of clinical problems (paralysis and jerking muscle tremor)

Asuming a definition as weak as the previous ones, several diseases could be included inside the MS-spectrum. Other authors use a clinical definition of MS and its variants[6]. Clinical definitions refer to the lesions and their location, but not to the nature of the lesions and this kind of definitions are potentially heterogeneous. As with any definition, patients have to be considered non-affected until the definition conditions are satisfied.

Probably the most implicitly used definition can be found into the McDonald criteria proposal, which is the currently the gold standard for MS diagnosis. Any diagnosis criteria has to rely directly on the definition of what is diagnosed, or on another previous criteria. McDonald et al. seem to consider MS defined only by existence of lesions in the CNS when they say "the only proved diagnosis of MS can be made upon autopsy, or occasionally upon biopsy, where lesions typical of MS can be directly detected through standard histopathological techniques""[6]. Unfortunately they do not specify what they understand for "lesions typical of MS" nor whether to account for spinal cord lesions.

[edit] Diseases included in this category

The list of these diseases depends of the author, but usually are included:

  • Optic-spinal MS, or Opticospinal, variant which often include visual symptoms and have a more severe course than typical MS. Though multiple scars (scleroses) are present in CNS, and sometimes Poser criteria classifies it as clinically definite multiple sclerosis[7], currently is considered outside the scope of Multiple Sclerosis and inside the scope of Devic's disease[8], though is not sure if this applies to all cases[9].
  • Devic's disease, currently considered a separate disease
  • Acute disseminated encephalomyelitis or ADEM, a closely related disorder in which a known virus or vaccine triggers autoimmunity against myelin.
  • Balo concentric sclerosis, an unusual presentation of plaques forming concentrenic circles, which can sometimes get better spontaneously.
  • Schilder disease or diffuse myelinoclastic sclerosis: is a rare disease that presents clinically as a pseudotumoural demyelinating lesion; and is more common in children.[10][11]
  • Marburg multiple sclerosis, an aggressive form, also known as malignant, fulminant or acute MS.

Other variants have been proposed:

  • Pediatric and pubertal MS: MS cases are rare before puberty, but they can happen. Whether they constitute a separate disease is still an open subject. Anyway, even this pubertal MS could be more than one disease, because early-onset and late-onset have different demyelination patterns[14]
  • Venous multiple sclerosis: A relationship has been proposed between MS and Chronic cerebrospinal venous insufficiency. The hypothetical MS variant produced by CCSVI is called Venous Multiple Sclerosis. If this hypothesis is confirmed, this variant would acccount for most of MS cases.

As MS is an active field for research, the list is not closed or definitive. For example, some diseases like Susac's syndrome (MS has an important vascular component [15]) or autoimmune variants of peripheral neuropathies like Guillain-Barré syndrome or Progressive inflammatory neuropathy could be included assuming the autoimmune model.

[edit] Variants inside standard MS

[edit] Progressive variants

Some authors also think that primary progressive multiple sclerosis should be considered a different entity from standard MS[16] [17]. Others maintain the opposite[18]. In any case, the lesions in PPMS can be diffused instead of the normal focal ones.[19] Finally, also a dual classification of these diseases has been proposed, according to the shape of edges of the scars, in MS-like and ADEM-like[20]

[edit] Subclinical, preclinical, CIS and CDMS

The first manifestation of MS is the so called Clinically isolated syndrome, or CIS, which is the first isolated attack. The current diagnosis criteria for MS does not allow doctors to give an MS diagnosis until a second attack takes place. Therefore the concept of "clinical MS", for a MS that can be diagnosed has been developed. Until MS diagnosis has been established, nobody can tell whether the disease dealing with is MS.

Cases of MS before the CIS are sometimes found during other neurological inspections and are referred to as subclinical MS.[21] Preclinical MS refers to cases after the CIS but before the confirming second attack.[22]. After the second confirming attack the situation is referred to as CDMS (clinically defined multiple sclerosis)[23].

[edit] See also

[edit] References

  1. ^ Fontaine B (2001). "[Borderline forms of multiple sclerosis]" (in French). Rev. Neurol. (Paris) 157 (8-9 Pt 2): 929–34. PMID 11787357. 
  2. ^ Wingerchuk DM, Lucchinetti CF (2007). "Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis". Curr. Opin. Neurol. 20 (3): 343–50. doi:10.1097/WCO.0b013e3280be58d8. PMID 17495631. 
  3. ^ Poser CM, Brinar VV (October 2007). "Disseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical review". Acta Neurol Scand. 116 (4): 201–6. doi:10.1111/j.1600-0404.2007.00902.x. PMID 17824894. 
  4. ^ Weinshenker B, Miller D (1998). "Multiple sclerosis: one disease or many?". in Thompson AB, Siva A, Kesselring J. Frontiers in Multiple Sclerosis (2nd ed.). London: Taylor & Francis Group. pp. 37­–46. ISBN 1-85317-506-4. 
  5. ^ Hartung HP, Grossman RI (May 2001). "ADEM: distinct disease or part of the MS spectrum?". Neurology 56 (10): 1257–60. PMID 11376169. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=11376169. 
  6. ^ McDonald WI, Compston A, Edan G, et al. (2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis [1]". Ann. Neurol. 50 (1): 121–7. doi:10.1002/ana.1032. PMID 11456302. 
  7. ^ Kalanie H, Kholghie Y, Shamsai GR, Ghorbani M (October 2008). "Opticospinal multiple sclerosis in Iran". J Neurol Sci.. doi:10.1016/j.jns.2008.09.038. PMID 18962726. 
  8. ^ Kira J (October 2008). "Neuromyelitis optica and asian phenotype of multiple sclerosis". Ann NY Acad Sci. 1142: 58–71. doi:10.1196/annals.1444.002 (inactive 2008-12-06). PMID 18990121. 
  9. ^ Matsushita T, Isobe N, Matsuoka T, Shi N, Kawano Y, Wu X, Yoshiura T, Nakao Y, Ishizu T, Kira J. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese PMID 19465451
  10. ^ Garrido C, Levy-Gomes A, Teixeira J, Temudo T (2004). "[Schilder's disease: two new cases and a review of the literature]" (in Spanish). Revista de neurologia 39 (8): 734–8. PMID 15514902. 
  11. ^ Afifi AK, Bell WE, Menezes AH, Moore SA (1994). "Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature". J. Child Neurol. 9 (4): 398–403. PMID 7822732. 
  12. ^ Lucchinetti CF, Gavrilova RH, Metz I, et al. (July 2008). "Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis". Brain 131 (Pt 7): 1759–75. doi:10.1093/brain/awn098. PMID 18535080. 
  13. ^ Given CA, Stevens BS, Lee C (1 January 2004). "The MRI appearance of tumefactive demyelinating lesions". AJR Am J Roentgenol 182 (1): 195–9. PMID 14684539. http://www.ajronline.org/cgi/content/full/182/1/195. 
  14. ^ Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E (September 2008). "Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?". Neurology 71 (14): 1090–3. doi:10.1212/01.wnl.0000326896.66714.ae. PMID 18824673. 
  15. ^ Minagar A, Jy W, Jimenez JJ, Alexander JS (2006). "Multiple sclerosis as a vascular disease". Neurol. Res. 28 (3): 230–5. doi:10.1179/016164106X98080. PMID 16687046. 
  16. ^ Vukusic S, Confavreux C (2003). "Primary and secondary progressive multiple sclerosis". J. Neurol. Sci. 206 (2): 153–5. doi:10.1016/S0022-510X(02)00427-6. PMID 12559503. 
  17. ^ Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F (2006). "Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis". Acta Neurol. Scand. 114 (6): 368–73. doi:10.1111/j.1600-0404.2006.00700.x. PMID 17083335. 
  18. ^ Ebers GC (2004). "Natural history of primary progressive multiple sclerosis". Mult. Scler. 10 Suppl 1: S8–13; discussion S13–5. doi:10.1191/1352458504ms1025oa. PMID 15218804. 
  19. ^ Zwemmer JN, Bot JC, Jelles B, Barkhof F, Polman CH (April 2008). "At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only". Mult Scler. 14 (3): 428–30. doi:10.1177/1352458507084591. PMID 18208890. 
  20. ^ Poser CM, Brinar VV (2004). "The nature of multiple sclerosis". Clinical neurology and neurosurgery 106 (3): 159–71. doi:10.1016/j.clineuro.2004.02.005. PMID 15177764. 
  21. ^ Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP. (2008). Subclinical MS: follow-up of four cases. PMID 18507677. 
  22. ^ Lebrun C, Bensa C, Debouverie M, et al. (2008). "Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile". J Neurol Neurosurg Psychiatry 79 (2): 195–198. doi:10.1136/jnnp.2006.108274. PMID 18202208. 
  23. ^ Frisullo G, Nociti V, Iorio R, et al. (December 2008). "The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis". J Neuroimmunol. 205 (1-2): 126–34. doi:10.1016/j.jneuroim.2008.09.003. PMID 18926576. 



Product Results (view all...)

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 



↑ top of page ↑about thumbshots